Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report

Victor J. Dzau(Brigham and Women's Hospital), Michael Weber(Medical University of Vienna), Heribert Schunkert(University of Regensburg), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Ahsan Husain(Emory University), Eva Lonn(McMaster University), Björn Dahlöf, Ton J. Rabelink(Leiden University Medical Center), David S. Celermajer(Children's Hospital at Westmead), Marcel Ruzicka(University of Ottawa), Willem J. Remme(AstraZeneca (United Kingdom)), Burkhard Hornig(Uppsala University), Douglas E. Vaughan(Brigham and Women's Hospital), John Deanfield(Great Ormond Street Hospital), Luís M. Ruilope(Brigham and Women's Hospital), Thomas Unger(Christian-Albrechts-Universität zu Kiel), Carl J. Pepine(Providence College), Javier Dı́ez(Universidad de Navarra), A Mimran(Hôpital Lapeyronie), Karl Swedberg(Sahlgrenska University Hospital), Roberto Ferrari(University of Ferrara), Colin I. Johnston(Baker Heart and Diabetes Institute), Jerome D. Cohen(Brigham and Women's Hospital), Lennart Hansson(Uppsala University), Helmut Drexler(University of Freiburg), Thomas F. Lüscher(King's College - North Carolina), Harold L. Lazar(Boston Medical Center), John Mancini(Vancouver General Hospital), Wiek H. van Gilst(University Medical Center Groningen)
Cardiovascular Drugs and Therapy
March 1, 2002
Cited by 133


Related Papers